CARE Ratings (BOM:534804) Cyclically Adjusted Revenue per Share: ₹131.87 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:534804 CARE Ratings Ltd BOM:534804
85 GF Score
Price ₹1,683.85
GF Value ₹1,768.54
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is CARE Ratings Cyclically Adjusted Revenue per Share?

CARE Ratings BOM:534804 -1.32% 85 Cyclically Adjusted Revenue per Share is ₹131.87 as of Jun. 2026. GuruFocus rates BOM:534804 with a GF Score™ of 85/100 and a GF Value™ of ₹1,768.54 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CARE Ratings's adjusted revenue per share for the three months ended in Jun. 2026 was ₹37.043. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹131.87 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-03), CARE Ratings's current stock price is ₹1683.85. CARE Ratings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹131.87. CARE Ratings's Cyclically Adjusted PS Ratio of today is 12.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CARE Ratings was 13.95. The lowest was 11.59. And the median was 12.67.


CARE Ratings  (BOM:534804) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CARE Ratings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1683.85/131.87
=12.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CARE Ratings was 13.95. The lowest was 11.59. And the median was 12.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CARE Ratings Cyclically Adjusted Revenue per Share Related Terms


CARE Ratings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CARE Ratings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARE Ratings Cyclically Adjusted Revenue per Share Chart

CARE Ratings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 128.29

CARE Ratings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 125.55 127.10 128.29 131.87

BOM:534804 vs SPGI, CME, ICE: Cyclically Adjusted Revenue per Share Comparison

For the Financial Data & Stock Exchanges subindustry, CARE Ratings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CARE Ratings Cyclically Adjusted PS Ratio vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CARE Ratings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CARE Ratings's Cyclically Adjusted PS Ratio falls into.


BOM:534804
85GF Score
CARE Ratings Ltd BOM:534804
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARE Ratings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CARE Ratings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=37.043/167.3573*167.3573
=37.043

Current CPI (Jun. 2026) = 167.3573.

CARE Ratings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201706 21.375 107.109 33.398
201709 31.541 109.021 48.418
201712 25.947 109.404 39.692
201803 32.967 109.786 50.255
201806 20.353 111.317 30.599
201809 32.813 115.142 47.693
201812 25.035 115.142 36.388
201903 30.039 118.202 42.531
201906 16.936 120.880 23.448
201909 24.320 123.175 33.043
201912 19.041 126.235 25.244
202003 22.397 124.705 30.057
202006 12.676 127.000 16.704
202009 25.762 130.118 33.135
202012 18.829 130.889 24.075
202103 26.890 131.771 34.152
202106 16.263 134.084 20.299
202109 24.766 135.847 30.511
202112 18.300 138.161 22.167
202203 22.218 138.822 26.785
202206 18.408 142.347 21.642
202209 28.585 144.661 33.070
202212 20.962 145.763 24.067
202303 26.122 146.865 29.767
202306 22.338 150.280 24.876
202309 32.326 151.492 35.711
202312 26.331 152.924 28.816
202403 30.056 153.035 32.869
202406 26.301 155.789 28.254
202409 39.115 157.882 41.462
202412 32.028 158.323 33.856
202503 36.465 157.552 38.734
202506 31.182 159.755 32.666
202509 45.265 162.289 46.679
202512 37.202 163.281 38.131
202603 43.306 164.272 44.119
202606 37.043 167.357 37.043

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹131.87 mean?
CARE Ratings (BOM:534804) has a Cyclically Adjusted Revenue per Share of ₹131.87 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CARE Ratings and its competitors.
Is CARE Ratings' Cyclically Adjusted Revenue per Share too high?
CARE Ratings' current Cyclically Adjusted Revenue per Share is ₹131.87. Overall, CARE Ratings has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' Cyclically Adjusted Revenue per Share compare to SPGI and CME?
CARE Ratings' Cyclically Adjusted Revenue per Share of ₹131.87 can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Capital Markets company?
A good Cyclically Adjusted Revenue per Share depends on the Capital Markets industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CARE Ratings and its competitors. CARE Ratings's current Cyclically Adjusted Revenue per Share is ₹131.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (BOM:534804) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,768.54, compared to a current price of ₹1,683.85 — trading 4.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹131.87. CARE Ratings' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CARE Ratings (BOM:534804), the current Cyclically Adjusted Revenue per Share is ₹131.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CARE Ratings (BOM:534804) Overvalued in 2026?

Based on GuruFocus' analysis, CARE Ratings stock appears to be undervalued. The current stock price of ₹1,683.85 is trading 4.8% below its estimated GF Value™ of ₹1,768.54. GuruFocus considers CARE Ratings to be Fairly Valued.

Key valuation signals for BOM:534804:

  • Cyclically Adjusted Revenue per Share: ₹131.87
  • GF Value™: ₹1,768.54 vs. price of ₹1,683.85 (4.8% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CARE Ratings Business Description

Other Exchanges CARERATING:India
Address Somaiya Hospital Road, Off Eastern Express Highway, 4th Floor, Godrej Coliseum, Sion (East), Mumbai, MH, IND, 400 022
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
85GF Score

Get the complete analysis for BOM:534804

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,683.85
Price
₹1,768.54
GF Value